Active Volume Stock: Boston Scientific Corporation (NYSE:BSX)

Tuesday, 13 Mar, 2018

The institutional investor held 390,000 shares of the medical and dental instruments company at the end of 2017Q3, valued at $11.38 billion, down from 420,546 at the end of the previous reported quarter. BMO Capital Markets reiterated a "buy" rating and set a $31.00 price target on shares of Boston Scientific in a research report on Wednesday, November 29th. The stock decreased 0.79% or $0.1 during the last trading session, reaching $12.6. About 1.92 million shares traded or 187.31% up from the average.

Boston Scientific (NYSE:BSX) last posted its quarterly earnings data on Thursday, February 1st. It has outperformed by 2.42% the S&P500.

Pictet & Cie Europe Sa decreased its stake in Newell Brands Inc (NWL) by 59.43% based on its latest 2017Q3 regulatory filing with the SEC. American Century Companies Inc. now owns 10,496,489 shares of the medical equipment provider's stock worth $306,183,000 after purchasing an additional 2,352,297 shares in the last quarter. The stock decreased 0.17% or $0.24 during the last trading session, reaching $137.04. About 735,117 shares traded. (NYSE:KEG) has 0.00% since March 12, 2017 and is. It has outperformed by 14.75% the S&P500. After $1.53 actual earnings per share reported by Union Pacific Corporation for the previous quarter, Wall Street now forecasts 8.50% EPS growth. Sirios Capital Management L P now owns 1,896,262 shares of the medical equipment provider's stock valued at $55,314,000 after purchasing an additional 1,495,821 shares during the period.

Pura Vida Investments Llc increased Viewray Inc stake by 346,370 shares to 607,040 valued at $3.50 billion in 2017Q3.

Since September 29, 2017, it had 0 insider purchases, and 14 sales for $15.61 million activity. Therefore 78% are positive. Union Pacific Corporation had 105 analyst reports since July 24, 2015 according to SRatingsIntel. The company presently has an average rating of "Buy" and an average target price of $31.06. The rating was initiated by Johnson Rice with "Buy" on Thursday, September 21. The stock has "Buy" rating by Canaccord Genuity on Wednesday, January 17. The company was maintained on Tuesday, August 4 by Cowen & Co. The firm earned "Buy" rating on Thursday, July 20 by Oppenheimer. The rating was upgraded by Piper Jaffray on Wednesday, March 29 to "Overweight". On Friday, December 4 the stock rating was downgraded by Bank of America to "Neutral". The firm has "Buy" rating by Piper Jaffray given on Friday, February 23. Its up 0.07, from 1.16 in 2017Q2. 95 funds opened positions while 408 raised stakes. It also upped Sarepta Therapeutics Inc (NASDAQ:SRPT) stake by 20,000 shares and now owns 50,000 shares. Nippon Life Insur Com accumulated 62,876 shares or 0.03% of the stock. $10.11 million worth of Boston Scientific Corporation (NYSE:BSX) was sold by Bose Supratim on Tuesday, October 3. Cambridge Investment Research Advsr Inc has 12,377 shares. Colorado-based Denver Investment Limited Liability has invested 0.06% in Union Pacific Corporation (NYSE:UNP). Shelton Capital Mngmt holds 11,526 shares. Cibc Mkts holds 210,977 shares or 0.06% of its portfolio. Bessemer Gru holds 0% or 20,400 shares. Mairs And reported 9,680 shares. Amp Invsts Ltd invested in 0.1% or 619,153 shares. North Star Asset Mgmt has invested 1.25% of its portfolio in Union Pacific Corporation (NYSE:UNP). Moreover, Meiji Yasuda Asset Mngmt Limited has 0.12% invested in FedEx Corporation (NYSE:FDX) for 5,632 shares.

Investors sentiment increased to 1.34 in Q3 2017. Its up 0.30, from 1.04 in 2017Q2. It increased, as 33 investors sold BSX shares while 166 reduced holdings. 122 funds opened positions while 336 raised stakes. Vanguard Grp owns 95.24M shares. Arrowstreet Capital Limited Partnership now owns 7,149,847 shares of the medical equipment provider's stock valued at $177,245,000 after acquiring an additional 5,633,721 shares during the period. Fukoku Mutual Life, Japan-based fund reported 8,744 shares. Employees Retirement Systems Of Texas has 0.2% invested in Boston Scientific Corporation (NYSE:BSX). Salem Mngmt invested 4.97% of its portfolio in Microsoft Corporation (NASDAQ:MSFT). The stock of Boston Scientific Corporation (NYSE:BSX) has "Buy" rating given on Thursday, July 23 by Benchmark. Manchester Management Ltd Liability Corporation owns 6,957 shares. Greystone Management Limited holds 138,958 shares or 4.98% of its portfolio. Prudential Incorporated has invested 0.23% in Boston Scientific Corporation (NYSE:BSX). New Amsterdam Prns Lc New York owns 18,088 shares for 0.56% of their portfolio.

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. It also reduced its holding in Schlumberger Ltd (NYSE:SLB) by 7,165 shares in the quarter, leaving it with 39,730 shares, and cut its stake in Costco Whsl Corp (NASDAQ:COST).

Boston Scientific Corporation (NYSE:BSX) received a Buy rating from 3 analysts. Therefore 68% are positive. The firm has "Hold" rating given on Thursday, August 13 by TheStreet. The rating was maintained by Jefferies on Friday, February 2 with "Hold". The firm has "Buy" rating given on Thursday, June 22 by Needham. The company was maintained on Wednesday, November 29 by Stifel Nicolaus. As per Monday, October 2, the company rating was maintained by RBC Capital Markets. BTIG Research maintained the stock with "Hold" rating in Monday, June 26 report.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.